Drug-resistance of gonorrhea in the EU: Persistent but stable
Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP). This threatens the effectiveness of the currently recommended dual therapy regimen for gonorrhoea. Overall, the rates of resistance to cefixime, ceftriaxone and azithromycin have remained stable when compared to recent years.
from Health & Medicine News -- ScienceDaily https://ift.tt/2PSy68j
from Health & Medicine News -- ScienceDaily https://ift.tt/2PSy68j
Comments
Post a Comment